FDA product code NBC: Test, Natriuretic Peptide
NBC is the FDA product code for test, natriuretic peptide. It is a Class II device, regulated under 21 CFR 862.1117 and reviewed by the Clinical Chemistry panel. FDA has cleared 46 510(k) submissions under NBC, 9 in the last five years, from 18 different applicants. The average 510(k) review took 156 days (median 104); 220 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 22 recalls for NBC devices.
Classification
| Field | Value |
|---|---|
| Device name | Test, Natriuretic Peptide |
| Device class | Class II |
| Regulation | 21 CFR 862.1117 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) |
510(k) clearances per year for NBC
| Year | Clearances | Avg. review days |
|---|---|---|
| 2020 | 1 | 360 |
| 2021 | 2 | 352 |
| 2022 | 1 | 399 |
| 2023 | 2 | 414 |
| 2024 | 1 | 266 |
| 2025 | 1 | 262 |
| 2026 | 4 | 132 |
Compare with all 510(k) review times · Search every NBC clearance
Top NBC applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Biosite Incorporated | 8 | 2008-06-06 |
| Dade Behring, Inc. | 6 | 2007-08-17 |
| Bayer Healthcare, LLC | 5 | 2005-06-13 |
| Beckman Coulter, Inc. | 4 | 2026-10-20 |
| Roche Diagnostics Corp. | 4 | 2010-02-04 |
13 more applicants have NBC clearances. See the full list in Caduvo.
Most recent NBC clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262597 | Beckman Coulter, Inc. | Access BNP II | 2026-10-20 | 85 |
| K262109 | Beckman Coulter, Inc. | Access NT-proBNP | 2026-09-21 | 90 |
| K252169 | Beckman Coulter, Inc. | Access BNP II | 2026-03-24 | 257 |
| K253539 | Axis-Shield Diagnostics, Ltd. | Alere NT-proBNP for Alinity i | 2026-02-18 | 97 |
| K241176 | Axis-Shield Diagnostics, Ltd. | Alere NT-proBNP for Alinity i Reagent Kit | 2025-01-16 | 262 |
Recalls for NBC devices
22 product recalls in 18 recall events; 0 initiated in the last five years and 2 still open. Most recent: 2020-10-01.
| Year | Recalls |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
Frequently asked questions
What is FDA product code NBC?
NBC is the FDA product code for test, natriuretic peptide. It is a Class II device, regulated under 21 CFR 862.1117 and reviewed by the Clinical Chemistry panel.
What device class is NBC?
Class II, regulation 21 CFR 862.1117. Typical premarket route: 510(k).
How long does a 510(k) take for product code NBC?
Across 46 cleared submissions the average was 156 days from receipt to decision (median 104).
Which companies have the most NBC clearances?
Biosite Incorporated (8); Dade Behring, Inc. (6); Bayer Healthcare, LLC (5); Beckman Coulter, Inc. (4); Roche Diagnostics Corp. (4).
Have NBC devices been recalled?
Yes: 22 product recalls across 18 recall events; the most recent began 2020-10-01.
Next steps
- Run an FDA pathway report with predicate devices for product code NBC
- Run a recall and safety report across every NBC manufacturer
- Watch product code NBC for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times